ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 701383 Null 0.0202245331784474 0.55052895
NSC 703109 Null 0.0202245331784474 0.3542044
NSC 703117 Null 0.0202245331784474 0.17371674
NSC 709483 Null 0.0202245331784474 0.42585558
NSC 710716 Null 0.0202245331784474 0.26004335
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0202245331784474 0.40183268
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0202245331784474 0.15444226
NSC 726267 Null 0.0202245331784474 -0.0066652397
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0202245331784474 0.20561095
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0202245331784474 0.31720084
Total:151  Current:83    [First] [Prev] [Next] [Last]